Malumbres M, Barbacid M: Mammalian cyclin-dependent kinases. Trends Biochem Sci. Morgan DO: Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. Nat Rev Cancer. BMC Evol Biol. Mol Biol Evol. Nat Genet. Mol Microbiol. Dev Cell. Cell Cycle. Trends Cell Biol. Cell Div. BMC Genomics. Biochim Biophys Acta. Google Scholar. J Mol Biol. Mol Cell Biol. Good targets?. Genes Dev. Malumbres M, Barbacid M: To cycle or not to cycle: a critical decision in cancer.
Rubin SM: Deciphering the retinoblastoma protein phosphorylation code. Arif A: Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5.
Biochem Pharmacol. J Biol Chem. Trends Genet. DNA Repair Amst. Nat Struct Mol Biol. Curr Opin Cell Biol. Sci Rep. Mol Cell. Cell Rep. J Biochem. Biochem Biophys Res Commun. EMBO Rep. J Cell Sci. J Cell Biol. PubMed Article Google Scholar. J Clin Invest. Cancer Cell. Breakthrough therapies. Cancer Res. Mol Phylogenet Evol. Download references. You can also search for this author in PubMed Google Scholar.
Correspondence to Marcos Malumbres. Reprints and Permissions. Malumbres, M. Cyclin-dependent kinases. Genome Biol 15, Download citation. Published : 30 June Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Zhou Z. Cell Div. Senft D. Ubiquitin ligases in oncogenic transformation and cancer therapy. Hanahan D. Hallmarks of cancer: The next generation. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Sanchez-Martinez C. Canavese M. Cyclin dependent kinases in cancer: Potential for therapeutic intervention.
Cancer Biol. Cao L. Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages. BMC Evol. Cicenas J. The CDK inhibitors in cancer research and therapy. Cancer Res. To cycle or not to cycle: A critical decision in cancer. Watanabe N. EMBO J. Genes Dev. Okuda M. Sever-Chroneos Z. Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.
Gavet O. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Santamaria D. Cdk1 is sufficient to drive the mammalian cell cycle. Giannone G. Ren S. Zhao H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.
Santo L. Matsuoka S. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Koniaras K. Harvey S. Cdk1-dependent regulation of the mitotic inhibitor Wee1.
Musacchio A. Lara-Gonzalez P. The spindle assembly checkpoint. Whittaker S. Inhibitors of cyclin-dependent kinases as cancer therapeutics.
Suh H. Jeronimo C. Galbraith M. Therapeutic targeting of transcriptional cyclin-dependent kinases. Allen B. The Mediator complex: A central integrator of transcription. Yin J. The Mediator complex: A master coordinator of transcription and cell lineage development.
Lim S. Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Fisher R. Genes Cancer. Larochelle S. Peterlin B. Controlling the elongation phase of transcription with P-TEFb. Viladevall L. Blazek D. Clemente-Blanco A. Cdc14 phosphatase promotes segregation of telomeres through repression of RNA polymerase II transcription. Guillamot M. Horiuchi D. Chen Y. Marais A. Nie L. CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Zhang X. Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels. Cell Commun. Zhang Z. Cao T. Pozo K. The role of Cdk5 in neuroendocrine thyroid cancer. Cancer Cell. Dorand R. Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity. NavaneethaKrishnan S. Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore.
Targeting Cdk5 for killing of breast cancer cells via perturbation of redox homeostasis. Liang Q. CDK5 is essential for TGF-beta1-induced epithelial-mesenchymal transition and breast cancer progression. Wang Y. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Nemet J. Firestein R. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Crown J. CDK8: A new breast cancer target. Broude E. Cancer Drug Targets. Schlafstein A. Breast Cancer.
Del Re M. Breast Cancer Res. Guen V. You Y. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report. Cell Oncol. Dordr ; 38 — Iorns E. Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.
Dos Santos Paparidis N. Loyer P. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: Influence of cyclin L isoforms on splice site selection. Chi Y. Critical role of CDK11 p58 in human breast cancer growth and angiogenesis. BMC Cancer. The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Keen, N. Aurora-kinase inhibitors as anticancer agents.
Cancer 4 , — Cell cycle kinases in cancer. Emerging cancer therapeutic opportunities by inhibiting mitotic kinases. Petronczki, M. Polo on the rise — from mitotic entry to cytokinesis with Plk1. Cell 14 , — Strebhardt, K. Targeting polo-like kinase 1 for cancer therapy. Taylor, S. Polo and Aurora kinases: lessons derived from chemical biology. CDK inhibitors in cancer therapy: what is next? Trends Pharmacol. Shapiro, G. Cyclin-dependent kinase pathways as targets for cancer treatment.
Larochelle, S. Li, T. Iorns, E. Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 13 , 91— Chandramouli, A. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Boveri, T. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11 , 25—36 Farmer, H. An elegant proof of principle of the therapeutic value of inducing synthetic lethal alterations in tumours.
Huang, D. Pho85, a multifunctional cyclin-dependent protein kinase in budding yeast. Nebreda, A. CDK activation by non-cyclin proteins. Bloom, J. Multiple levels of cyclin specificity in cell-cycle control. Ren, S. Ye, X. A premature-termination mutation in the Mus. Zhang, J. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Maestre, C.
Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. Fisher, R. Secrets of a double agent: CDK7 in cell-cycle control and transcription. Cell Sci. Loyer, P. Cell Signal 17 , — Firestein, R. Morris, E. References and illustrate the role of CDK8, a CDK not directly implicated in the cell cycle, in human tumour development. Petretti, C. EMBO Rep. Wilker, E. Yokoyama, H. Cdk11 is a RanGTP-dependent microtubule stabilization factor that regulates spindle assembly rate.
Hu, D. CDK11 p58 is required for the maintenance of sister chromatid cohesion. Hampsey, M. Synchronicity: policing multiple aspects of gene expression by Ctk1. Chen, H. Martin, J. Oncogene 22 , — Mettus, R. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Jirawatnotai, S. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. Moons, D. Pituitary hypoplasia and lactotroph dysfunction in mice deficient for cyclin-dependent kinase Endocrinology , — Cooperation between Cdk4 and p27 kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Hartwell, L. Genetic control of the cell-division cycle in yeast. Detection of mutants. USA 66 , — Nurse, P. Genetic control of cell size at cell division in yeast. Evans, T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.
Cell 33 , — Lee, M. Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature , 31—35 DeCaprio, J. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58 , — Buchkovich, K. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.
Chen, P. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Weinert, T. Control of G2 delay by the rad9 gene of Saccharomyces cerevisiae. Suppl 12 , — Xiong, Y. Human D-type cyclin. Cell 65 , — Matsushime, H.
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Lew, D. Isolation of three novel human cyclins by rescue of G1 cyclin Cln function in yeast. Cell 66 , — Cell 71 , —34 Donehower, L. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Farmer, G. Wild-type p53 activates transcription in vitro. Nature , 83—86 Hupp, T. Regulation of the specific DNA binding function of p Cell 71 , — E2Fs can then act as transcriptional activators for genes needed in the S phase.
When and only when all six sites are phosphorylated which takes a while , Sic1 is released, whereupon it gets poly ubiquitinated and therefore degraded by the proteasome. These two control three major transiations in the cell cycle:. An example is Sic1 above. CDK1 has two phosphorylation sites in vertebrates; only one in yeast at amino acids Y15 and T In animals, phosphorylation of Y15 is inhibitory, while phosphorylation of T is activating. Cdc25 overexpression results in premature removal of this Y15 phosphorylation so that the cell enters the M phase before it has had enough time to grow during the G2 phase.
Once a cell passes the restriction point R in late G1, it is committed to passing through the S phase. Many cancers involve a loss of p16 leading to cyclin D1 overexpression. Other cancers esp. Here is an overview of what are considered to be the 9 fundamental steps of cell cycle regulation. Cell starts in phase G0 or G1. Step 7 relies on a mechanism to recognize unreplicated DNA and stalled replication forks in order to ensure that mitosis does not proceed before all DNA has been replicated.
0コメント